US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ascletis Pharma Inc.

0.9325

0.0000

Volume:- -

Turnover:- -

Market Cap:910.85M

PE:-22.65

High:0.9325

Open:0.9325

Low:0.9325

Close:0.9325

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Ascletis Pharma Inc.

Exchange:

PINK

Establishment Date:

2013

Employees:

231

Office Location:

12/F, Building D,198 Qidi Road, HIPARK,Xiaoshan District,Hangzhou,Zhejiang Province,China

Website:

- -

Zip Code:

311200

Phone:

86 571 8538 9730

Fax:

86 571 8538 9730

Introduction:

Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China and internationally. The company offers Ritonavir oral tablet, a pharmacokinetic booster of various oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid; ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also developing ASC22 for treating chronic hepatitis B (CHB); ASC42 for chronic hepatitis B functional cure; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, ASC42, ASC43F FDC, ASC44F FDC, and ASC45F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma, drug resistant breast cancer, and KRAS mutant non-small cell lung cancer; ASC61 and ASC63 for advanced solid tumors; ASC60 to treat solid tumors; and ASC40 for the treatment of acne. Ascletis Pharma Inc. was founded in 2013 and is headquartered in Hangzhou, the People's Republic of China.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ASCLF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ASCLF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASCLF\",,,,,undefined,":{"symbol":"ASCLF","market":"US","secType":"STK","nameCN":"Ascletis Pharma Inc.","latestPrice":0.9325,"timestamp":1749844800000,"preClose":0.9325,"halted":0,"volume":0,"delay":15,"floatShares":145496269,"shares":976782000,"eps":-0.041164,"marketStatus":"Market Closed","change":0,"latestTime":"06-13 16:00:00 EDT Delay","open":0.9325,"high":0.9325,"low":0.9325,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.041164,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750060800000},"marketStatusCode":7,"adr":0,"exchange":"PINK","adjPreClose":0.9325,"volumeRatio":0.4761904217687136},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASCLF\",,,,,undefined,":{"symbol":"ASCLF","floatShares":145496269,"roa":"-10.96%","roe":"-13.97%","lyrEps":-0.041164,"volumeRatio":0.4761904217687136,"shares":976782000,"dividePrice":0,"high":0.9325,"amplitude":0,"preClose":0.9325,"low":0.9325,"week52Low":0.1402,"pbRate":"3.33","psRate":"5107.57","week52High":1.2,"institutionHeld":0,"latestPrice":0.9325,"eps":-0.041164,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.041164,"open":0.9325,"prevYearClose":0.2393,"prevWeekClose":0.9325,"prevMonthClose":0.9325,"prevQuarterClose":1.2,"fiveDayClose":0.9325,"twentyDayClose":0.8478,"sixtyDayClose":1.0439},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":574413177,"yearFounded":2013,"employeeNum":231,"address":"12/F, Building D,198 Qidi Road, HIPARK,Xiaoshan District,Hangzhou,Zhejiang Province,China","zipCode":"311200","officePhone":"86 571 8538 9730","officeFax":"86 571 8538 9730"},"stockCompanyDetail":{"description":"Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China and internationally. The company offers Ritonavir oral tablet, a pharmacokinetic booster of various oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid; ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also developing ASC22 for treating chronic hepatitis B (CHB); ASC42 for chronic hepatitis B functional cure; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, ASC42, ASC43F FDC, ASC44F FDC, and ASC45F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma, drug resistant breast cancer, and KRAS mutant non-small cell lung cancer; ASC61 and ASC63 for advanced solid tumors; ASC60 to treat solid tumors; and ASC40 for the treatment of acne. Ascletis Pharma Inc. was founded in 2013 and is headquartered in Hangzhou, the People's Republic of China.","exchange":"PINK","name":"Ascletis Pharma Inc.","nameEN":"Ascletis Pharma Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ASCLF\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ASCLF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-08-22","symbol":"ASCLF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1661140800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ASCLF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ASCLF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.25,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":4,"updateTime":1743566400000}}}